The long noncoding RNA-H19/miRNA-93a/ATG7 axis regulates the sensitivity of pituitary adenomas to dopamine agonists
The long noncoding RNA-H19/miRNA-93a/ATG7 axis regulates the sensitivity of pituitary adenomas to dopamine agonists
复制标题
长非编码RNA-H19/miRNA-93a/ATG7轴调节垂体腺瘤对多巴胺激动剂的敏感性
DOI:
10.1016/j.mce.2020.111033
复制
发表时间:
2020-09
期刊:
影响因子:
--
通讯作者:
Zhe Bao Wu
中科院分区:
文献类型:
--
作者:
Zerui Wu;Yong Zhi Zheng;Wan Qun Xie;Qun li;Yong Zhang;Bo Han Ren;Lin Cai;Yijun Cheng;Hao Tang;Zhipeng Su;Zhe Bao Wu
Dopamine agonists (DAs), such as cabergoline and bromocriptine, are the first-line clinical treatment for prolactinomas. Our previous study demonstrated that long noncoding RNA H19 expression is frequently downregulated in human primary pituitary adenomas and is negatively correlated with tumor progression. However, the significance and mechanism of H19 in the DA treatment of prolactinomas are still unknown. In this study, we reported that H19 had a synergistic effect with DA treatment on prolactinomas in vitro andin vivo. Mechanistically, H19 promoted ATG7 expression in pituitary tumor cells by inhibiting miR-93a expression. In addition, a potential binding site between miR-93 and H19 was confirmed, and low expression of miR-93 was previously found in DA-resistant prolactinomas. Furthermore, we showed that miR-93a regulates ATG7 expression by targeting ATG7 mRNA. In conclusion, our study has identified the role of the H19-miR-93-ATG7 axis in DA treatment of prolactinomas, which may be a potential therapeutic target for human prolactinomas.
登录
查看更多内容
影响因子:
4.1
作者:
Wu, Zhe Bao;Li, Wei Qiang;Zhao, Wei Guo
通讯作者:
Zhao, Wei Guo
影响因子:
9
作者:
Liu, Yingqiang;Chen, Xijuan;Ge, Hong
通讯作者:
Ge, Hong
影响因子:
4.6
作者:
Chen, Shuo;Wang, Li-li;Zhao, Yang
通讯作者:
Zhao, Yang
影响因子:
6.7
作者:
Fanini, F.;Fabbri, M.
通讯作者:
Fabbri, M.
影响因子:
9.7
作者:
Jia, Peng;Cai, Heng;Xue, Yixue
通讯作者:
Xue, Yixue